Showing results (221-230 of 1,011) with videos related to
Sort By:
Pageof 102
Scandinavian Journal of Haematology|October 1, 1975
Analysis of a fibrin formation abnormality in a case of multiple myelomaJ Soria, C Soria, M Samama, et al.Thrombosis and Haemostasis|April 1, 1994
Expression of a paternal history of premature myocardial infarction on fibrinogen, factor VIIC and PAI-1 in European offspring--the EARS study. European Atherosclerosis Research Study GroupL Bara, V Nicaud, L Tiret, et al.Journal of Stomatology, Oral and Maxillofacial Surgery|October 13, 2017
Mandibular lymphomaS Vo Quang, L Sicard, M Samama, et al.Thrombosis Research|September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adultsMeyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.Thrombosis Research. Supplement|January 1, 1990
Degradation of fibrinogen by tissue plasminogen activator. Consequences for fibrin polymerizationM Mirshahi, J Soria, C Soria, et al.Anesthesie, Analgesie, Reanimation|January 1, 1980
[Congenital deficiency of factor XI: diagnosis and therapy in surgical patients (author's transl)]A Robert, C Huguet, H Conard, et al.Haemostasis|January 1, 1981
Study of platelet diameter distribution in patients with valvular heart disease and with prosthetic heart valve replacementM Dumoulin, M Tirmarche, M H Horellou, et al.Annales De Medecine Interne|January 1, 1988
[The eccentriplate device on the Dideco Vivacell cell separator for the collection of platelets]G Andreu, A Gautheron, A Nicod-Tran, et al.Thrombosis Research|December 15, 1988
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activityJ M Walenga, M Petitou, M Samama, et al.Haemostasis|January 1, 1983
Molar antithrombin concentration in normal human plasmaJ Conard, F Brosstad, M Lie Larsen, et al.Pageof 102